35分钟小学生大片_365亚洲最新线路网址_37pao免费视频国产

CHIFENG WANZE PHARMACEUTICAL CO.,LTD.

Medical and biological industry report comments: industry boom continued to rise, the future is opti

The pharmaceutical industry is continuously improving, and individual stocks are differentiated.In the first half of the year, A shares pharmaceutical sector listed companies achieved operating income of 284 billion 371 million yuan, comparable companies rose 19.97%; total profit of 23 billion 173 million yuan, comparable companies grew by 24.12%.Profit growth is significantly greater than income growth.The loss of Listed Companies in the industry is only 14, a decrease of 10 compared with last year, the loss of 84.37% year-on-year decline.According to the latest data released by the National Bureau of statistics, in 2017 July, the total profit of pharmaceutical manufacturing increased by 18.70%,industry profit growth began to appear bottoming recovery after a significant slowdown in 2016 before the situation.Industry boom continued to improve.At the same time, we statistics comparable data of 223 pharmaceutical segment listed companies, net profit growth of more than 50% a total of 47, an increase of 30-50% in a total of 30, an increase of 0-30% in 68, the performance of the decline or loss of 78.Overall, most of the pharmaceutical companies have achieved positive growth in performance, but the performance differentiation is more serious.

The achievement is growing ,plate price performance continues to improve.A shares of pharmaceutical industry listed companies in the first half of the year overall operating income increased by 19.97%, the total profit increased by 24.12%.Profit growth is significantly greater than income growth.For the second half, we believe that in the new version of medical insurance catalog adjustment, grading treatment and generic drug consistency evaluation policy driven background, the high growth of pharmaceutical plate performance is still a high probability event.As of August 31st, the overall price earnings ratio of the pharmaceutical sector was 38 times, compared with the overall A shares excluding the financial industry premium rate of 34.99%,was at a relatively low level.If our industry profit growth rate is about 20% in 2017, the corresponding overall valuation is about 33 times, the plate price performance or continue to improve.

Investment strategy: pay attention to three areas in the future.In the first half  year under the overall consumption plate collective strong background, some of the big market capitalization, underestimate the value of Baima pharmaceutical stocks also gained good gains.However, the cyclical industry and financial sector began to strengthen in July, causing the "seesaw" effect in the market,So that some of the early record of good stocks rose a big adjustment,with the environmental protection verification started, some sectors of the industry stock expected performance exceeded expectations, generics consistency evaluation policy and innovative drugs priority review mechanism continues to promote, raw materials, growth hormone, high-quality generic drugs and other related targets began to get investor ’s attention.On the whole, we believe that in the early stage of good growth in the varieties, there are still some varieties worthy of attention, although its valuation and performance of the degree of matching declined slightly,But endogenous high growth and relatively low valuation make it still have a high performance price ratio.In addition,  in the background that the market gradually strengthened, investors risk appetite began to rise,we focus on the following three areas:1,Investment opportunities for CRO and premium generics firms driven by generic consistency evaluation policy,relevant object: Tiger medicine, Huadong medicine, Shanghai medicine, Huarun Shuanghe, Salubris;2,Investment opportunities in grassroots market driven by hierarchical diagnosis and treatment policy, relevant object: Chinese medicine, pharmacy, old people, Yifeng Yixintang, Lingrui pharmaceutical, sunflower pharmaceutical, high-tech Changchun;3,Investment opportunities of chemical raw material drugs under strict environmental protection inspection,relevant object: Guangji pharmaceutical, northeast pharmaceutical.



Enterprise introduction


CHIFENG WANZE PHARMACEUTICAL CO.,LTD. is a comprehensive pharmaceutical company which set scientific research and exploitation, active pharmaceutical ingredients, preparation, food, cosmetics production, processing trade, domestic marketing, international trade as a whole.It is located at No.3,Wanze Road, Hongshan Economic Development Zone, Chifeng,covers an area of 84,000 square meters.


Contact information

——

Office 0476-8210903

Domestic Sales Department

Sales of ginseng thorn ointment 18665615118

Sales of API/Preparation 35分钟小学生大片_365亚洲最新线路网址_37pao免费视频国产0476-8210890

International Sales Department0476-8210833

Purchasing Department 35分钟小学生大片_365亚洲最新线路网址_37pao免费视频国产0476-8210891

QA 35分钟小学生大片_365亚洲最新线路网址_37pao免费视频国产0476-8210885

Equipment Department35分钟小学生大片_365亚洲最新线路网址_37pao免费视频国产0476-8210906

website qrcode

Scan and view the mobile web site

3d污动漫视频免费观看_3x短视频_404视频网站 免费永久网站 404午夜大片免费看_4080yy私人定制影院_4080yy私人影院亚洲免费 4080青苹果私人影院_4080私人影院_4080私人影院视大全 4080私人影院手机版_4080万达私人影院_4080影院官网 4388x全国最大成网站免费_4438com免费观看国产_4438成人网 4438亚洲最大免费网站_4438最大成网免费视频_4444kkkk免费电影 4444kk亚洲日韩中文_4455ee精品视频在线_4455ee免费在线观看 4455ee日本高清_4455ee日本高清在线观看_4455ee在线播放 4455日本高清电影_4484永久免费视频_4484在线观看视频 4484在线观看视频 完整版_4hucom四虎在线直播_50路母亲と息子の亲子